
A glimpse at what to expect from Dermatology Times this week.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes 2021 updates for acne, the link between collagen degeneration and rosacea, the effects of COVID-19 on the healthcare industry, plus more.

An online survey conducted in late-2020 shows what drove vaccine hesitancy.

In late 2020, our sister publication, Medical Economics®, conducted a Physicians Report asking physician audiences what they thought would be the most challenging issues they will face this year. Here is what the respondents said.

This was the first genome-wide association study of skin pigmentation in African Americans, according to the study authors.

This week’s edition of The Mainstream Patient features stories on aloe vera in skincare, fungal acne, the COVID-19 plastic surgery boom, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes a new podcast episode and stories on a new E-BPO for rosacea, a quick guide to regenerative aesthetic medicine, cutaneous side effects seen in COVID vaccine patients, plus more.

Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose. Experts assure that while the delayed side effect is uncomfortable, it is temporary and can be treated at home.

This week’s edition of The Mainstream Patient features stories on pore vacuums, psoriasis on POC skin, the difference between fillers and Botox, how to treat scars, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes stories on how mask usage worsens rosacea, why trichometric analysis is the key to finding an effective hair loss treatment, why some acne treatments are targeting the sebaceous gland, and more.

This week’s edition of The Mainstream Patient features stories on dermaplaning, active skincare ingredients, the history of Botox, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes content on the benefits of precision medicine, caring for LGBTQ+ patients, a new Legal Eagle column, how trichoscopy can aid with diagnosis of hair disorders, plus more.

A 17-year-old male patient presents with multiple lesions developed on his trunk, face, and extremities that had previously been solitary, red expanding lesion on his right arm at the site of a tick bite that occurred during a hike.

Angelo Landriscina, MD, FAAD, discusses how to care for your LGBTQ+ patients while also effectively addressing their different dermatologic needs.

With up to 30% of pediatric health care visits involving skin complaints and fewer than 400 board-certified pediatric dermatologists in the United States, teledermatology offers a valuable tool for increasing access and cutting wait times.

This is the first overhaul in a quarter century that simplifies evaluation and management and increases flexibility.

CDC advises not to delay shingles vaccination.

This week’s edition of The Mainstream Patient features stories on psoriatic arthritis diagnosis, treating eczema on darker skin types, the efficacy of pore vacuums, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes articles on the oral, narrow-spectrum antibiotics for acne, the best practices for atopic dermatitis care, oxytocin and its effect on skin aging, plus more.

In this video interview with Dermatology Times, one expert discusses how narrow-spectrum antibiotics can both protect the skin and gut microbiome, as well as effectively treat acne.

Watch one expert detail the benefits and limitations when using oral antibiotics for the treatment of acne.

This week’s edition of The Mainstream Patient features stories on psoriatic arthritis medication, “slugging” to treat cystic acne, chemical peels for darker skin types, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes articles on the multiple modalities to revise scars, the future of dermatology, phase 3 results of tapinarof cream for plaque psoriasis, guidelines for the COVID-19 vaccine and dermal fillers, plus more.

ASDSA has issued a patient safety alert after videos surface online of children/teens self-injecting HA via “hyaluron pens”.

Joel Cohen, MD, gives a synopsis of a panel discussion he was recently a part of at the 2021 ODAC Dermatology, Aesthetic and Surgical Conference focusing on the postoperative treatment of scars using a variety of methods including lasers, filler and other modalities.